Jim Simons's position in Vertex Pharmaceuticals is currently worth $452 Million. That's 0.62% of their equity portfolio (18th largest holding). The first Vertex Pharmaceuticals trade was made in Q3 2013. Since then Jim Simons bought shares nineteen more times and sold shares on fifteen occasions. The stake costed the investor $246 Million, netting the investor a gain of 84% so far.